Eclat Pharmaceuticals focuses on the development, approval and commercialization of niche brands and generic products. In March 2012, Eclat Pharmaceuticals was acquired by Flamel Technologies. The valuation of Eclat Pharmaceuticals was undisclosed. Other terms of the deal were not released.
Eclat Pharmaceuticals Headquarter Location
699 Trade Center Blvd Suite A
Chesterfield, Missouri, 63005,
Predict your next investment
The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Eclat Pharmaceuticals is included in 1 Expert Collection, including Pharma Startups.
Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.